{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:37:44Z","timestamp":1764131864619,"version":"3.37.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Z503563\/1"],"award-info":[{"award-number":["MR\/Z503563\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>People with severe mental illness have high rates of obesity, type 2 diabetes, and cardiovascular disease. Emerging evidence suggests that metabolic dysfunction may be causally linked to the risk of severe mental illness. However, more research is needed to identify reliable metabolic markers which may have an impact on mental health outcomes, and to determine the mechanisms behind their impact. In the METPSY research study, we will investigate the relationship between metabolic markers and clinical outcomes of severe mental illness in young adults. We will recruit 120 young adults aged 16\u201325 years living in Scotland with major depressive disorder, bipolar disorder, schizophrenia, or no severe mental illness (controls) for a prospective observational study. We will assess clinical symptoms at three in-person visits (baseline, 6 months, and 12 months) using the Structured Clinical Interview for DSM-5, and collect blood samples at each of these visits for agnostic profiling of metabolic biomarkers through an untargeted metabolomic screen, using the rapid hydrophilic interaction liquid chromatography ion mobility mass spectrometry method (RHIMMS). Participants will also complete remote assessments at 3 and 9 months after the baseline visit: Ecological Momentary Assessments to measure mental health, wrist actigraphy to measure rhythms of rest and activity, and continuous glucose monitoring to measure metabolic changes. Throughout the 12-month enrolment period, we will also measure objective markers of sleep using a radar sleep monitor (Somnofy). Using advanced statistical techniques and machine learning analysis, we will seek to better understand the mechanisms linking metabolic health with mental health in young adults with schizophrenia, bipolar disorder, and severe depression.<\/jats:p>\n          <jats:p>\n            <jats:bold>Clinical trial number<\/jats:bold>: Not applicable<\/jats:p>","DOI":"10.1186\/s12888-025-06579-9","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:22:00Z","timestamp":1739452920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic biomarkers of clinical outcomes in severe mental illness (METPSY): protocol for a prospective observational study in the Hub for metabolic psychiatry"],"prefix":"10.1186","volume":"25","author":[{"given":"Arish Mudra","family":"Rakshasa-Loots","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Swiffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie F. M.","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stafford L.","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saturnino","family":"Luz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"3","key":"6579_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/wps.20069","volume":"12","author":"D Vancampfort","year":"2013","unstructured":"Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, et al. A meta-analysis of cardio\u2010metabolic abnormalities in drug na\u00efve, first\u2010episode and multi\u2010episode patients with schizophrenia versus general population controls. World Psychiatry. 2013;12(3):240\u201350.","journal-title":"World Psychiatry"},{"issue":"9690","key":"6579_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620\u20137.","journal-title":"Lancet"},{"issue":"7","key":"6579_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2016.16040442","volume":"174","author":"AP Rajkumar","year":"2017","unstructured":"Rajkumar AP, Horsdal HT, Wimberley T, Cohen D, Mors O, B\u00f8rglum AD, et al. Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry. 2017;174(7):686\u201394.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"6579_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ijnp\/pyaa097","volume":"24","author":"Y Mizuki","year":"2021","unstructured":"Mizuki Y, Sakamoto S, Okahisa Y, Yada Y, Hashimoto N, Takaki M, et al. Mechanisms underlying the comorbidity of schizophrenia and type 2 diabetes mellitus. Int J Neuropsychopharmacol. 2021;24(5):367\u201382.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"6579_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/eip.12749","volume":"13","author":"S Kucukgoncu","year":"2019","unstructured":"Kucukgoncu S, Kosir U, Zhou E, Sullivan E, Srihari VH, Tek C. Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: a systematic review and meta-analysis. Early Interv Psychiat. 2019;13(5):1021\u201331.","journal-title":"Early Interv Psychiat"},{"key":"6579_CR6","doi-asserted-by":"publisher","first-page":"951376","DOI":"10.3389\/fpsyt.2022.951376","volume":"13","author":"A Danan","year":"2022","unstructured":"Danan A, Westman EC, Saslow LR, Ede G. The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients. Front Psychiatry. 2022;13:951376.","journal-title":"Front Psychiatry"},{"issue":"2","key":"6579_CR7","doi-asserted-by":"publisher","first-page":"39459","DOI":"10.4088\/JCP.21m14022","volume":"83","author":"CV Calkin","year":"2022","unstructured":"Calkin CV, Chengappa KR, Cairns K, Cookey J, Gannon J, Alda M, et al. Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD study): a randomized, quadruple-masked, placebo-controlled clinical trial. J Clin Psychiatry. 2022;83(2):39459.","journal-title":"J Clin Psychiatry"},{"key":"6579_CR8","doi-asserted-by":"publisher","first-page":"1153648","DOI":"10.3389\/fpsyt.2023.1153648","volume":"14","author":"A Khaity","year":"2023","unstructured":"Khaity A, Mostafa Al-dardery N, Albakri K, Abdelwahab OA, Hefnawy MT, Yousef YA, et al. Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis. Front Psychiatry. 2023;14:1153648.","journal-title":"Front Psychiatry"},{"key":"6579_CR9","doi-asserted-by":"crossref","unstructured":"Quintero M, Stanisic D, Cruz G, Pontes JG, Costa TBBC, Tasic L. Metabolomic biomarkers in mental disorders: bipolar disorder and schizophrenia. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. 2019:271\u2013\u200993.","DOI":"10.1007\/978-3-030-05542-4_14"},{"key":"6579_CR10","unstructured":"Allport GW. The use of personal documents in psychological science. Social Science Research Council Bulletin. 1942."},{"key":"6579_CR11","doi-asserted-by":"crossref","unstructured":"Robinaugh DJ, Brown ML, Losiewicz OM, Jones PJ, Marques L, Baker AW. Towards a precision psychiatry approach to anxiety disorders with ecological momentary assessment: the example of panic disorder. Gen Psychiatry. 2020;33(1).","DOI":"10.1136\/gpsych-2019-100161"},{"issue":"5","key":"6579_CR12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10902-020-00324-7","volume":"22","author":"LP De Vries","year":"2021","unstructured":"De Vries LP, Baselmans BM, Bartels M. Smartphone-based ecological momentary assessment of well-being: a systematic review and recommendations for future studies. J Happiness Stud. 2021;22(5):2361\u2013408.","journal-title":"J Happiness Stud"},{"issue":"6","key":"6579_CR13","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, L\u00f6we B. An ultra-brief screening scale for anxiety and depression: the PHQ\u20134. Psychosomatics. 2009;50(6):613\u201321.","journal-title":"Psychosomatics"},{"issue":"10","key":"6579_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S0006-3223(96)00548-3","volume":"42","author":"EG Altman","year":"1997","unstructured":"Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman self-rating mania scale. Biol Psychiatry. 1997;42(10):948\u201355.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6579_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1037\/prj0000417","volume":"44","author":"E Moitra","year":"2021","unstructured":"Moitra E, Park HS, Ben-Zeev D, Gaudiano BA. Using ecological momentary assessment for patients with psychosis posthospitalization: opportunities for mobilizing measurement-based care. Psychiatr Rehabil J. 2021;44(1):43.","journal-title":"Psychiatr Rehabil J"},{"issue":"2","key":"6579_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1037\/pas0000959","volume":"33","author":"C Sancho-Domingo","year":"2021","unstructured":"Sancho-Domingo C, Carballo JL, Coloma-Carmona A, Buysse DJ. Brief version of the Pittsburgh Sleep Quality Index (B-PSQI) and measurement invariance across gender and age in a population-based sample. Psychol Assess. 2021;33(2):111.","journal-title":"Psychol Assess"},{"issue":"3","key":"6579_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11306-022-01871-1","volume":"18","author":"M Pi\u010dmanov\u00e1","year":"2022","unstructured":"Pi\u010dmanov\u00e1 M, Moses T, Cortada-Garcia J, Barrett G, Florance H, Pandor S, et al. Rapid HILIC-Z ion mobility mass spectrometry (RHIMMS) method for untargeted metabolomics of complex biological samples. Metabolomics. 2022;18(3):16.","journal-title":"Metabolomics"},{"issue":"4","key":"6579_CR18","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.econmod.2012.02.014","volume":"29","author":"E-I Dumitrescu","year":"2012","unstructured":"Dumitrescu E-I, Hurlin C. Testing for Granger non-causality in heterogeneous panels. Econ Model. 2012;29(4):1450\u201360.","journal-title":"Econ Model"},{"key":"6579_CR19","doi-asserted-by":"crossref","unstructured":"Hochreiter S. Long short-term memory. Neural Computation MIT- 1997.","DOI":"10.1162\/neco.1997.9.8.1735"},{"key":"6579_CR20","doi-asserted-by":"crossref","unstructured":"Oud JH, Delsing MJ. Continuous time modeling of panel data by means of SEM. Longitudinal research with latent variables. Springer. 2010;201\u201344.","DOI":"10.1007\/978-3-642-11760-2_7"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06579-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06579-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06579-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:22:04Z","timestamp":1739452924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06579-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6579"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06579-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study will be carried out in accordance with internationally recognised standards for ethical research and the Declaration of Helsinki. All participants will provide written informed consent to take part in the study. This study has received ethical approval from the NHS North of Scotland Research Ethics Committee (1) (REC reference: 24\/NS\/0138).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RKS has received consulting fees from Astra Zeneca and Alnylam, and speaking fees from Novo Nordisk, Eli Lilly, and Amryt, all relating to severe insulin resistance and\/or lipodystrophy. SML has been paid to give an educational talk on cognition in schizophrenia to employees of Kynexis. SLL is a cofounder of Dynamic Therapeutics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}